Companies / Verve Therapeutics, Inc.
Verve Therapeutics, Inc.
VERVCIK 1840574
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 21, 2021 | Casdin Partners Master Fund, L.P. 10% owner | Buy Open-market buy | Common Stock | $20.90M | +1.1M +83.49% | 2,417,596 | high |
| Jun 21, 2021 | Redmile Group, LLC 10% owner | Buy Open-market buy | Common Stock | $19.95M | +1.1M +118.44% | 1,936,530 | high |
| Jun 21, 2021 | Logos Global Management LP 10% owner | Buy Open-market buy | Common Stock | $7.03M | +370K | 370,000 | high |
| Jun 21, 2021 | Rock Springs Capital Management LP 10% owner | Buy Open-market buy | Common Stock | $7.03M | +370K +66.51% | 926,298 | high |
| Jun 21, 2021 | Novo Holdings A/S 10% owner | Buy Open-market buy | COMMON STOCK | $6.65M | +350K +78.96% | 793,265 | high |
| Jun 21, 2021 | Cormorant Asset Management, LP 10% owner | Buy Open-market buy | Common Stock | $5.22M | +275K +38.77% | 984,224 | high |
| Dec 23, 2021 | Kathiresan Sekar CEO | Sell Open-market sale | Common Stock | $2.27M | -57K -12.30% | 406,536 | medium |
| Dec 27, 2021 | Kathiresan Sekar CEO | Sell Open-market sale | Common Stock | $1.46M | -36K -8.12% | 412,093 | medium |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| VERV | — | 92539P101 |